Select Page

June 12, 2017 – TARRYTOWN, N.Y., – PGI Drug Discovery LLC (PsychoGenics), announced that Sunovion Pharmaceuticals Inc. filed an IND for SEP-378608 triggering a milestone payment to PsychoGenics in its drug discovery and development collaboration.